Sensory Integration Training for Older Adults With Mild Cognitive Impairment

March 10, 2026 updated by: Fatmagul Cayir, Akdeniz University

Investigation of the Effects of Sensory Integration Training on Cognitive Functions, Quality of Life, and Social Participation in Older Adults With Mild Cognitive Impairment

This study aims to investigate the effects of sensory integration training on cognitive functions, quality of life, and social participation in older adults with Mild Cognitive Impairment (MCI)

Study Overview

Status

Not yet recruiting

Detailed Description

Sensory impairments are highly prevalent among older adults and have significant effects on the cognitive and functional outcomes of aging. Although the relationship between sensory functions and cognitive processes has been clearly established in the literature, the underlying neurobiological and psychosocial mechanisms of this link are yet to be fully elucidated. In an era of increasing dementia prevalence, older individuals with sensory deficiencies constitute a critical and growing risk group that warrants investigation for a deeper understanding of cognitive aging. Epidemiological data indicate that impairments in visual, auditory, and other individual sensory systems are consistently associated with cognitive decline and the development of dementia.

In this context, our study proposes sensory integration training as a potential intervention to bridge the gap between sensory input and cognitive performance.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being between 65 and 85 years of age
  • Having a Montreal Cognitive Assessment (MoCA) score between 18 and 25, indicating mild cognitive impairment
  • Being in stable medical health, with no history of severe neurological or psychiatric disorders
  • Voluntary participation

Exclusion Criteria:

  • Clinical diagnosis of dementia or having moderate-to-severe cognitive impairment
  • Severe visual or hearing loss to a degree that prevents effective communication or participation in assessments
  • Presence of severe sensory, motor, or physical disabilities that render the intervention (e.g., walking or sensory training) impossible to perform
  • Acute medical conditions or having unstable chronic diseases that may pose a risk during physical activity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Aerobic Exercise
The aerobic exercise intervention consists of a 12-week outdoor walking program, performed twice weekly for 45 minutes per session at a moderate intensity, targeting a score of 12-14 on the Borg Rating of Perceived Exertion (RPE) scale
Experimental: Aerobic Exercise +Sensory Integration Training
The aerobic exercise intervention consists of a 12-week outdoor walking program, performed twice weekly for 45 minutes per session at a moderate intensity, targeting a score of 12-14 on the Borg Rating of Perceived Exertion (RPE) scale
The program includes activities that stimulate three main senses: vestibular (balance and movement), proprioceptive (body awareness), and tactile (touch). These exercises are designed to help the brain organize sensory signals more effectively to improve daily functions and cognitive performance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick Mild Cognitive Impairment Screen - Turkish Version
Time Frame: 6 months

Quick Mild Cognitive Impairment Screen - Turkish Version is a cognitive assessment tool consisting of six sub-headings covering at least five cognitive domains. The sub-headings and the cognitive domains they assess are defined as follows:

  1. Orientation: (Questioning the country, year, month, day, and date - approx. 1 minute - 10 points)
  2. Registration: (Working memory; repeating 5 given words - 30 seconds - 5 points)
  3. Clock Drawing: (Visuospatial; drawing a clock within 1 minute - 15 points)
  4. Delayed Recall: (Episodic memory; recalling the 5 previously mentioned words - 30 seconds - 20 points)
  5. Verbal Fluency: (Semantic memory/language; naming animals within 1 minute - 20 points)
  6. Logical Memory: (Episodic memory; repeating a short story - 1 minute - 30 points)

Scoring and Interpretation The test is evaluated out of a total of 100 points, where higher scores indicate better cognitive status. A score of 62 points or below indicates cognitive impairment.

6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
World Health Organization Quality of Life - Older Adults Module
Time Frame: 6 months
World Health Organization Quality of Life-Old module is a specialized 24-item instrument designed to evaluate the quality of life in older adults across six distinct domains, utilized via a five-point Likert scale. These domains include sensory abilities, which assesses the impact of sensory functions and their loss on quality of life; autonomy, reflecting independence and the ability to live and make decisions autonomously; past, present, and future activities, which measures satisfaction with life achievements and outlook on the future; social participation, focusing on engagement in daily community activities; death and dying, addressing concerns and anxieties related to the end of life; and intimacy, evaluating the capacity for personal and private relationships. Each item is scored on a scale from 1.0 to 5.0, resulting in potential domain scores ranging from a minimum of 4 to a maximum of 20. A total cumulative score is calculated by summing the individual item v
6 months
Lubbes Social Network Scale-6
Time Frame: 6 months
Lubbes Social Network Scale-6 is a specialized instrument comprising six items designed to evaluate the size of a social network, private communication (confiding), and the availability of reciprocal help. The scale is structured into two subscales, with three questions dedicated to family ties and three to friendship networks. Consistent with the original version, each item is rated on a six-point Likert scale ranging from 0 to 5. In this scoring system, individual scores of 0, 1, and 2 indicate a limited or deficient social network, whereas scores of 3, 4, and 5 signify a more extensive and robust social network. The total score is calculated by summing the values of all items, resulting in a range from 0 to 30. Higher total scores on the LSNS-6 are indicative of a greater presence of social network ties and more significant social engagement.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 15, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

March 10, 2026

First Posted (Actual)

March 12, 2026

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 10, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment (MCI)

Clinical Trials on Aerobic Exercise

Subscribe